Trial Profile
Treatment of Severe HCV Recurrence after Liver Transplantation with Sofosbuvir Based Regimen: Aisf-Sofolt Italian Compassionate use Program
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Peginterferon; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Aug 2015 New trial record